Chemical Planet

Growing consumer awareness regarding infant health is expected to be the key factor driving the market. Moreover, heavy investments by prominent companies in emerging economies is anticipated to fuel the industry growth. The global infant formula market was valued at over USD 45.0 billion in 2016, with Asia being the dominant region. The Global Human Milk Oligosaccharides (HMO) Market size is expected to reach USD 71.2 billion by 2025, according to a new report by Grand View Research, Inc. The HMO market is projected to witness a strong CAGR of 21.9% during the forecast period. Increasing number of middle-class households and number of working women are among the key reasons behind the growth of the infant formula market. Presence of numerous companies and resultant competition in this sector is likely to facilitate the usage of HMO in infant formula over the forecast period, boosting the market growth. High demand for dietary supplements owing to increased health consci

Increasing application scope in functional beverages and infant formula is expected to have a positive impact on growth. The Global Human Milk Oligosaccharides Market is expected to reach USD 170.4 million by 2024, according to a new report by Grand View Research, Inc. Lack of protective enzymes in general infant formula and in breastfed milk, leading to high infant mortality rate, is likely to augment human milk oligosaccharides market growth. In 1990, the mortality rate of infants was 63 deaths per 1,000 live births, and in 2015, the rate declined to only 32 deaths per 1,000 live births. Growth of functional food & beverage industry in China, Brazil, India, Poland, South Korea, and Mexico is also likely to propel growth over the forecast period. Rising disposable income and increasing concerns of middle class population towards health issues in emerging economies such as India and China are also expected to be key factors contributing to market growth for dietary